Bio-Rad Laboratories (BIO) Announces Acquisition of QuantaLife for $162 million
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Join SI Premium – FREE
Bio-Rad Laboratories, Inc. (NYSE: BIO) announced today that it has purchased QuantaLife, Inc. for $162 million in cash plus potential future milestone payments.
QuantaLife has developed an innovative digital PCR system that provides quantification of target molecules with unprecedented precision and sensitivity.
QuantaLife has developed an innovative digital PCR system that provides quantification of target molecules with unprecedented precision and sensitivity.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stripe, Advent In Talks To Buy Paypal - WSJ
- SpaceX acquires Cursor in $60 billion all-stock deal
- Proficient Auto Logistics completes Hansen & Adkins acquisition
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
